Leptin has been identified as a key member of the obesity-breast cancer molecular network influencing several aspects of breast cancer initiation, growth, metastatic progression as well as response to therapy [13-19]. The gene discussed is LEP; the disease is obesity due to melanocortin 4 receptor deficiency.